Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 12/2010

01-12-2010 | Original paper

In conclusion: looking to the future of comprehensive cancer control

Authors: Lori Belle Isle, Marcus Plescia, Madeline La Porta, Walter Shepherd

Published in: Cancer Causes & Control | Issue 12/2010

Login to get access

Abstract

The articles in this monograph illustrate the progress and successes of comprehensive cancer control (CCC) since our 2005 publication. The strides made in CCC demonstrate the energy and commitment of this nationwide movement to reduce the burden of cancer for all people. The purpose of this conclusion paper is to discuss the future of CCC, which promises a new emphasis on policy, primary prevention, public health, evidence-based interventions, and global health supported by advanced communication tools.
Literature
1.
Frieden TR (2010) A framework for public health action: the health impact pyramid. AJPH 100(4):590–595CrossRef
2.
McDonough JE, Gibbs BK, Scott-Harris JL et al (2004) A state policy agenda to eliminate racial and ethnic health disparities. Commonwealth fund, available at www.​cmwf.​org. Accessed June 15, 2010
3.
Mokdad AH, Marks JS, Stroup DF, Gerberding JL (2004) Actual causes of death in the United States, 2000. JAMA 291(10):1238–1245CrossRefPubMed
4.
U.S. Department of Health and Human Services (2004) Health consequences of smoking: a report of the surgeon general. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA
5.
Smedley BD, Stith AY, Nelson AR (eds) (2003) Unequal treatment: confronting racial and ethnic disparities in healthcare. Institute of Medicine. National Academies Press, Washington, DC
6.
7.
Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27(17):2758–2765CrossRefPubMed
8.
Given L, Black B, Lowry G, Huang P et al (2005) Collaborating to conquer cancer: a comprehensive approach to cancer control. Cancer Causes Control 16(Suppl 1):8
9.
World Health Organization, cancer control knowledge into action, WHO guide for effective programmes, 2006
10.
11.
12.
13.
14.
Unpublished communication from Nancy Lins, Senior Officer, Office of Global Health, American Cancer Society, National Home Office
15.
16.
17.
Manhattan research, taking the pulse® v9.0. Physicians in 2012: the outlook for on demand, mobile, and social digital media
18.
19.
Fox S, Jones S (2009) The social life of health information: Americans’ pursuit of health takes place within a widening network of both online and offline sources. Pew Internet Am Life Proj
20.
21.
Metadata
Title
In conclusion: looking to the future of comprehensive cancer control
Authors
Lori Belle Isle
Marcus Plescia
Madeline La Porta
Walter Shepherd
Publication date
01-12-2010
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 12/2010
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9666-7

Other articles of this Issue 12/2010

Cancer Causes & Control 12/2010 Go to the issue

Original paper

Tobacco use cessation and weight management among motor freight workers: results of the gear up for health study

Original paper

Reproductive factors, menopausal hormone therapy, and risk of non-Hodgkin, diffuse large B-cell and follicular lymphomas: a UK case–control study

Original paper

Association between human papillomavirus and adenocarcinoma of rectum and recto-sigmoid junction: a cohort study of 10,612 women in Taiwan

Original paper

Association between body mass index and mortality in patients with glioblastoma mutliforme

Original paper

Toenail selenium status and the risk of Barrett’s esophagus: the Netherlands Cohort Study

Original paper

Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits